Financial Avengers’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$186K Buy
1,335
+8
+0.6% +$1.12K 0.08% 36
2025
Q4
$163K Buy
1,327
+8
+0.6% +$972 0.07% 37
2025
Q3
$146K Buy
1,319
+9
+0.7% +$1.02K 0.06% 38
2025
Q2
$145K Buy
1,310
+10
+0.8% +$1.06K 0.07% 38
2025
Q1
$146K Sell
1,300
-30
-2% -$3.1K 0.07% 40
2024
Q4
$123K Buy
1,330
+11
+0.8% +$990 0.06% 43
2024
Q3
$111K Buy
1,319
+12
+0.9% +$916 0.05% 45
2024
Q2
$89.7K Buy
1,307
+14
+1% +$934 0.05% 44
2024
Q1
$94.2K Buy
1,293
+13
+1% +$1K 0.05% 44
2023
Q4
$104K Buy
1,280
+12
+0.9% +$934 0.06% 40
2023
Q3
$95K Buy
1,268
+13
+1% +$1K 0.06% 43
2023
Q2
$96.8K Buy
1,255
+12
+1% +$957 0.06% 43
2023
Q1
$103K Buy
1,243
+11
+0.9% +$911 0.08% 36
2022
Q4
$106K Buy
1,232
+10
+0.8% +$792 0.09% 34
2022
Q3
$75K Buy
1,222
+14
+1% +$883 0.06% 41
2022
Q2
$75K Buy
1,208
+15
+1% +$929 0.06% 43
2022
Q1
$71K Sell
1,193
-948
-44% -$60.6K 0.04% 47
2021
Q4
$155K Sell
2,141
-17
-0.8% -$1.17K 0.1% 36
2021
Q3
$151K Sell
2,158
-229
-10% -$16.1K 0.1% 35
2021
Q2
$164K Buy
2,387
+24
+1% +$1.6K 0.11% 34
2021
Q1
$153K Sell
2,363
-130
-5% -$8.38K 0.11% 34
2020
Q4
$145K Buy
+2,493
New +$150K 0.12% 29

Other funds holding GILD

Financial Avengers's GILD Position: Q1 2026 in Review

Financial Avengers increased its Gilead Sciences (GILD) stake by 0.6% in Q1 2026, buying an estimated $1.12K and bringing the position to 1,335 shares worth $186K. The position accounts for 0.08% of the portfolio, ranked #36.

Financial Avengers first reported a position in GILD in Q4 2020 and has held it in 22 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Financial Avengers held 1,335 shares of Gilead Sciences worth $186K as of Q1 2026.
  • Financial Avengers bought 8 Gilead Sciences shares in Q1 2026, an estimated $1.12K.
  • Gilead Sciences made up 0.08% of Financial Avengers's portfolio in Q1 2026, its #36 holding.
  • Financial Avengers first reported a position in Gilead Sciences in Q4 2020 and has held it in 22 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Financial Avengers's 13F filing for Q1 2026, filed 19 May 2026.